Home › Merck's Vytorin first cholesterol drug to cut risk further
 

Keywords :   


Merck's Vytorin first cholesterol drug to cut risk further

2014-11-18 09:37:30| Biotech - Topix.net

Merck & Co.' s Vytorin reduced the risks of second heart attacks and strokes in patients already on aggressive therapy, making it the first medicine to improve on the current standard of care for lowering cholesterol.

Tags: further risk cut drug

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
06.10Glatfelter Develops Biobased Espresso Lid Material
06.10Tropical Storm Milton Potential Storm Surge Flooding Map
06.10Tropical Storm Milton Probabilistic Storm Surge Graphics
06.10Firms urge mayor to rethink congestion charge plan
06.10Tropical Storm Milton Public Advisory Number 5
06.10Summary for Tropical Storm Milton (AT4/AL142024)
06.10Tropical Storm Milton Graphics
06.10Tropical Storm Milton Graphics
More »